RESTRICTED STOCK UNIT AWARD AGREEMENT UNDER THE BRIDGEBIO PHARMA, INC. AMENDED AND RESTATED 2019 INDUCEMENT EQUITY PLANRestricted Stock Unit Award Agreement • August 3rd, 2023 • BridgeBio Pharma, Inc. • Pharmaceutical preparations
Pursuant to the BridgeBio Pharma, Inc. Amended and Restated 2019 Inducement Equity Plan as amended through the date hereof (the “Plan”), BridgeBio Pharma, Inc. (the “Company”) hereby grants an award of the number of Restricted Stock Units listed above (an “Award”) to the Grantee named above. Each Restricted Stock Unit shall relate to one share of Common Stock, par value $0.001 per share (the “Stock”) of the Company. This Award is granted as an “employment inducement award” pursuant to the exemption provided by Rule 5635(c)(4) of the Marketplace Rules of the NASDAQ Stock Market, Inc.
NON-QUALIFIED STOCK OPTION AGREEMENTNon-Qualified Stock Option Agreement • August 3rd, 2023 • BridgeBio Pharma, Inc. • Pharmaceutical preparations
NON-QUALIFIED STOCK OPTION AGREEMENT UNDER BRIDGEBIO PHARMA, INC. AMENDED AND RESTATED 2019 INDUCEMENT EQUITY PLANNon-Qualified Stock Option Agreement • August 3rd, 2023 • BridgeBio Pharma, Inc. • Pharmaceutical preparations
NON-QUALIFIED STOCK OPTION AGREEMENT FOR DIRECTORS UNDER THE 2021 AMENDED AND RESTATED BRIDGEBIO PHARMA, INC. STOCK OPTION AND INCENTIVE PLANNon-Qualified Stock Option Agreement • August 3rd, 2023 • BridgeBio Pharma, Inc. • Pharmaceutical preparations
RESTRICTED STOCK AWARD AGREEMENT UNDER THE 2021 AMENDED AND RESTATED BRIDGEBIO PHARMA, INC. STOCK OPTION AND INCENTIVE PLANRestricted Stock Award Agreement • August 3rd, 2023 • BridgeBio Pharma, Inc. • Pharmaceutical preparations
Pursuant to the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan (the “Plan”) as amended through the date hereof, BridgeBio Pharma, Inc. (the “Company”) hereby grants a Restricted Stock Award (an “Award”) to the Grantee named above. Upon acceptance of this Award, the Grantee shall receive the number of shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above, subject to the restrictions and conditions set forth herein and in the Plan. The Company acknowledges the receipt from the Grantee of consideration with respect to at least the par value of the Stock in the form of cash, past or future services rendered to the Company by the Grantee or such other form of consideration as is acceptable to the Administrator.
RESTRICTED STOCK AWARD AGREEMENT UNDER THE BridgeBio Pharma, INC. AMENDED AND RESTATED 2019 INDUCEMENT EQUITY PLANRestricted Stock Award Agreement • August 3rd, 2023 • BridgeBio Pharma, Inc. • Pharmaceutical preparations
Pursuant to the BridgeBio Pharma, Inc. Amended and Restated 2019 Inducement Equity Plan (the “Plan”) as amended through the date hereof, BridgeBio Pharma, Inc. (the “Company”) hereby grants a Restricted Stock Award (an “Award”) to the Grantee named above. Upon acceptance of this Award, the Grantee shall receive the number of shares of Common Stock, par value $0.001 per share (the “Stock”) of the Company specified above, subject to the restrictions and conditions set forth herein and in the Plan. The Company acknowledges the receipt from the Grantee of consideration with respect to at least the par value of the Stock in the form of cash, past or future services rendered to the Company by the Grantee or such other form of consideration as is acceptable to the Administrator. This Award is granted as an “employment inducement award” pursuant to the exemption provided by Rule 5635(c)(4) of the Marketplace Rules of the NASDAQ Stock Market, Inc.
